Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
KU.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
KU.1NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
KZ.1ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
KZ.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
KZ.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
KZ.1NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
JN.1.36ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
JN.1.36ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
JN.1.36ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
JN.1.36NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
JQ.2.1ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
JQ.2.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
JQ.2.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
JQ.2.1NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
KT.1ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
KT.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
KT.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
KT.1NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
LA.2ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
LA.2ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
LA.2ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
LA.2NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
LH.1ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
LH.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
LH.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
LH.1NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
JN.16ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
JN.16ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
JN.16ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
JN.16NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
LN.1.1ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
LN.1.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
LN.1.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
LN.1.1NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
JN.1.25.1ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
JN.1.25.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
JN.1.25.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
JN.1.25.1NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
JN.1.16.2ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
JN.1.16.2ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
JN.1.16.2ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
JN.1.16.2NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
JN.1.57.1ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
JN.1.57.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
JN.1.57.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
JN.1.57.1NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
JN.1.44.1ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
JN.1.44.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
JN.1.44.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
JN.1.44.1NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used